CLU and Alzheimer disease: Downregulation of TMAO levels in plasma could alleviate the neuroinflammatory state of AD model mice, as indicated by the significant reductions in plasma clusterin, together with IL-2, IL-17, and TNF-α levels in the hippocampus [36,37].